154 related articles for article (PubMed ID: 24156100)
1. Response to Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism.
Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
Hypertension; 2013 Oct; 62(4):e14. PubMed ID: 24156100
[No Abstract] [Full Text] [Related]
2. Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism.
Kaplan N
Hypertension; 2013 Oct; 62(4):e13. PubMed ID: 23918755
[No Abstract] [Full Text] [Related]
3. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
5. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy?
Auchus RJ; Drazner MH
Hypertension; 2007 Nov; 50(5):837-9. PubMed ID: 17909118
[No Abstract] [Full Text] [Related]
6. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
7. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
Marzano L; Colussi G; Sechi LA; Catena C
Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
[TBL] [Abstract][Full Text] [Related]
8. Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study.
Adolf C; Görge V; Heinrich DA; Hoster E; Schneider H; Handgriff L; Künzel H; Sturm L; Beuschlein F; Reincke M
Hypertension; 2021 Apr; 77(4):1332-1340. PubMed ID: 33641355
[TBL] [Abstract][Full Text] [Related]
9. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
Morimoto S; Ichihara A
Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary hyperaldosteronism.
Araujo-Castro M
Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
Stavropoulos K; Papadopoulos C; Koutsampasopoulos K; Lales G; Mitas C; Doumas M
Curr Pharm Des; 2018; 24(46):5508-5516. PubMed ID: 30854950
[TBL] [Abstract][Full Text] [Related]
12. Hyperaldosteronism: diagnosis, lateralization, and treatment.
Harvey AM
Surg Clin North Am; 2014 Jun; 94(3):643-56. PubMed ID: 24857581
[TBL] [Abstract][Full Text] [Related]
13. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
[TBL] [Abstract][Full Text] [Related]
14. Primary aldosteronism and low-renin hypertension: a continuum?
Funder JW
Nephrol Dial Transplant; 2013 Jul; 28(7):1625-7. PubMed ID: 23535225
[No Abstract] [Full Text] [Related]
15. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
17. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism.
Lechner B; Lechner K; Heinrich D; Adolf C; Holler F; Schneider H; Beuschlein F; Reincke M
Eur J Endocrinol; 2019 Oct; 181(4):R147-R153. PubMed ID: 31299637
[TBL] [Abstract][Full Text] [Related]
18. Primary aldosteronism and pregnancy.
Morton A
Pregnancy Hypertens; 2015 Oct; 5(4):259-62. PubMed ID: 26597737
[TBL] [Abstract][Full Text] [Related]
19. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
20. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
Hundemer GL
Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]